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Saccharomyces cerevisiae as terpenoid factories
Evamaria Gruchattka1†, Oliver Hädicke2, Steffen Klamt2, Verena Schütz1,3† and Oliver Kayser1*†Abstract
Background: Heterologous microbial production of rare plant terpenoids of medicinal or industrial interest is attracting
more and more attention but terpenoid yields are still low. Escherichia coli and Saccharomyces cerevisiae are the
most widely used heterologous hosts; a direct comparison of both hosts based on experimental data is difficult
though. Hence, the terpenoid pathways of E. coli (via 1-deoxy-D-xylulose 5-phosphate, DXP) and S. cerevisiae (via
mevalonate, MVA), the impact of the respective hosts metabolism as well as the impact of different carbon sources
were compared in silico by means of elementary mode analysis. The focus was set on the yield of isopentenyl
diphosphate (IPP), the general terpenoid precursor, to identify new metabolic engineering strategies for an
enhanced terpenoid yield.
Results: Starting from the respective precursor metabolites of the terpenoid pathways (pyruvate and glyceraldehyde-
3-phosphate for the DXP pathway and acetyl-CoA for the MVA pathway) and considering only carbon stoichiometry,
the two terpenoid pathways are identical with respect to carbon yield. However, with glucose as substrate, the MVA
pathway has a lower potential to supply terpenoids in high yields than the DXP pathway if the formation of the
required precursors is taken into account, due to the carbon loss in the formation of acetyl-CoA. This maximum yield is
further reduced in both hosts when the required energy and reduction equivalents are considered. Moreover, the
choice of carbon source (glucose, xylose, ethanol or glycerol) has an effect on terpenoid yield with non-fermentable
carbon sources being more promising. Both hosts have deficiencies in energy and redox equivalents for high yield
terpenoid production leading to new overexpression strategies (heterologous enzymes/pathways) for an enhanced
terpenoid yield. Finally, several knockout strategies are identified using constrained minimal cut sets enforcing a
coupling of growth to a terpenoid yield which is higher than any yield published in scientific literature so far.
Conclusions: This study provides for the first time a comprehensive and detailed in silico comparison of the most
prominent heterologous hosts E. coli and S. cerevisiae as terpenoid factories giving an overview on several
promising metabolic engineering strategies paving the way for an enhanced terpenoid yield.
Keywords: Terpenoids, Isoprenoids, In silico, Elementary mode analysis, Constrained minimal cut sets, Metabolic
engineering, Escherichia coli, Saccharomyces cerevisiaeBackground
Terpenoids are a class of natural products with important
medicinal and industrial applications such as artemisinin
(antimalarial) or paclitaxel (anticancer) [1,2]. However,
several of these bioactive compounds are scarce and pro-
duced only in low amounts in plants, which makes the
production in their native hosts uneconomical and* Correspondence: Oliver.Kayser@bci.tu-dortmund.de
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distribution, and reproduction in any mediumenvironmentally destructive [2]. The total chemical syn-
thesis of many terpenoids is challenging due to their com-
plex structure and neither ecologically nor economically
efficient [3-5]. Alternatively, the use of a microbial plat-
form organism for the production of terpenoids may offer
the possibility of large‐scale, cost‐effective and environ-
mentally friendly industrial production independent from
climate or cultivation risks. Today, Escherichia coli and
Saccharomyces cerevisiae are the most widely used micro-
organisms for heterologous terpenoid production. They
are preferably used due to advanced molecular biology
tools, growth speed and their well-established use intral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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production of carotenoid compounds of lower complexity
such as lycopene (an antioxidative carotenoid) have been
carried out in E. coli, the trends concerning the produc-
tion of artemisinin or paclitaxel show a more even dis-
tribution between these two hosts with an increasingly
more prevalent use of S. cerevisiae [5]. This trend might
partly be attributed to the fact that S. cerevisiae as an
eukaryotic organism has the advantage of being more
suitable than E. coli for the expression of membrane-
bound plant cytochrome P450 enzymes along with their
respective reductase [2] required for the functionalization
of a series of terpenoids [7-9]. A further advantage is the
possibility to harness different subcellular compartments
[10]. Moreover, yeast can withstand reduced pH and high
osmotic pressure [11] and is not susceptible to phage
infections.
The production of terpenoids in both organisms re-
quires a sufficient supply of their common precursor
isopentenyl diphosphate (IPP) and its isomer dimethylallyl
diphosphate (DMAPP), which are then condensed,
cyclized etc. leading to the structural diversity of terpe-
noids. E. coli and S. cerevisiae differ in their metabolic
routes to supply these precursors. The 1-deoxy-D-xylulose
5-phosphate (DXP) pathway of E. coli (often also called
2C-methyl-D-erythriol 4-phosphate pathway, MEP) is fed
by pyruvate and glyceraldehyde-3-phosphate whereas in
the mevalonate (MVA) pathway of S. cerevisiae IPP de-
rives from acetyl-CoA [12,13].
Attempts to engineer the DXP pathway in E. coli mainly
focused on the combinatorial overexpression of the rate
limiting enzymes encoded by dxs, idi, dxr, ispD and ispF
with various ranges of expression levels. Those studies
stressed the need to carefully balance the expression of the
DXP pathway genes with the heterologous terpenoid
forming pathway as well as with the host’s overall metab-
olism [14-21]. Alternatively, various examples show that
the introduction of an optimized MVA pathway efficiently
increases terpenoid production in E. coli, circumventing
the largely unidentified regulations of its native DXP path-
way and also decoupling the MVA pathway from its native
control in yeast [17,22-25].
Numerous engineering strategies have been applied es-
pecially to the MVA pathway in S. cerevisiae [11]. Three
particularly successful interventions have been described
in literature: i) overexpression of a truncated version of
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG1),
the key regulatory enzyme of the pathway, devoid of feed-
back inhibition by farnesyl diphosphate (FPP) [26-28]; ii)
downregulation of squalene synthase (ERG9) to reduce
the flux draining of FPP to biosynthetically related sterols
[29,30]; and iii) expression of a mutant transcription factor
(upc2-1) to transcriptionally up-regulate several MVA
pathway genes [7,8,31].A direct in vivo head-to-head comparison of both or-
ganisms and terpenoid pathways is difficult to interpret,
especially if it is considered that the expression of en-
zymes of both IPP forming pathways has to be balanced
carefully for optimal precursor supply and that E. coli
and S. cerevisiae differ in their central metabolic net-
works. However, in silico methods can reveal their theor-
etical potential and give further insight into the
properties of the underlying metabolic networks, thus
providing a rational basis for metabolic engineering.
Elementary mode analysis (EMA) is a key method-
ology to study essential properties of a metabolic net-
work. Elementary modes (EMs) characterize the space of
feasible steady-state flux distributions; any such flux dis-
tribution can be represented as a non-negative (conic)
linear combination of elementary modes. Based on the
stoichiometric matrix, the steady-state assumption,
thermodynamic constraints (reaction reversibilities) and
a non-decomposability constraint, elementary modes
can be calculated without the need for kinetic data, a
priori measurements, or an objective function [32-36].
EMA has been applied to calculate the overall capacity
of a given metabolic network, e.g. the theoretical max-
imum yield under a given genetic constitution or on
different substrates [32,37] in order to estimate the po-
tential efficiency of a biotechnological process. More-
over, it has been successfully used as a basis for the
computation of intervention strategies to obtain superior
production strains [32,38-41]. Recently, Hädicke et al.
[40] introduced the concept of constrained minimal cut
sets (cMCSs) to compute knockout strategies for
coupled product and biomass synthesis allowing not
only the specification of functionalities that are to be
disabled in the metabolic network but also of those that
have to be preserved. Furthermore, all equivalent knock-
out strategies to accomplish the same engineering goal
are computed, giving the researcher the flexibility to
choose the best combination of gene deletions in terms
of practical realization. cMCSs comprise and extend e.g.
the approach of minimal metabolic functionality [42] that
has been successfully applied multiple times in order to
identify metabolic engineering strategies [41-44].
In this study, EMA is applied to compare the metabolic
networks of E. coli and S. cerevisiae for the production of
the common terpenoid precursor IPP by means of carbon
stoichiometry, energy and redox equivalent requirements.
Further, the potential of the two hosts’ central metabolic
networks to meet those requirements if the MVA, the
DXP or both pathways are operating is analyzed. More-
over, the impact of different industrially relevant carbon
sources on IPP production is investigated in silico.
While most studies on terpenoid production mainly
focused on engineering the DXP and MVA pathway, only
a few studies deal with the identification of engineering
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proved precursor supply [31,41,45-50] leaving tremendous
room for further improvements. Therefore, the impact of
heterologously introduced enzymes is analyzed in silico
and knockout targets are computed based on constrained
minimal cut sets to give guidelines for metabolic en-
gineering in order to obtain a highly efficient IPP plat-
form organism.
Results and discussion
This section is conceptually divided into two parts. The
first subsection focuses on the analysis of the two ter-
penoid pathways starting with a comparison of the DXP
and MVA pathway independent from their host organ-
ism. Thereafter, the stoichiometric potential of E. coli
and S. cerevisiae to produce the precursor IPP is ana-
lyzed. For this purpose, models of the central carbon
metabolism were built up and analyzed (65 reactions
and 50 metabolites for E. coli and 69 reactions and 60
metabolites for S. cerevisiae, both for growth on glucose,
see Methods section and Additional file 1 for details).
Subsequently, the optimal flux distributions are charac-
terized and the impact of an interchange of the pathways
of E. coli and S. cerevisiae is investigated in silico. The
pathway analysis part is completed by analyzing alterna-
tive substrates and comparing the identified theoretically
optimal yields with available literature data. The results
of all these calculations are summarized in Table 1.
The second part of the results section is related to tar-
get identification for metabolic engineering. Suitable
heterologous overexpression candidates are identified
and promising knockout strategies are computed by
means of cMCSs.
Terpenoid pathway and metabolic network analysis
Stoichiometry of terpenoid pathways
The stoichiometry of both pathways is initially analyzed
independently from the respective host organism. The
precursors of the DXP pathway are glyceraldehyde-3-
phosphate (GAP) and pyruvate (PYR) and the overall
stoichiometry of this pathway is given by equation 1.
GAPþ PYRþ 3 NADPHþ 2 ATP
¼ IPPþ CO2 þ 3 NADPþ þ 2 ADP ð1Þ
The MVA pathway is fed by the carbon precursor
acetyl-CoA (AcCoA) and its stoichiometry is given by
equation 2.
3 AcCoAþ 2 NADPH þ 3 ATP
¼ IPPþ CO2 þ 2 NADPþ þ 3 ADP ð2Þ
Both terpenoid pathways lose one mol CO2 per mol IPP
(C5); therefore they are identical with respect to carbon
yield (5/6 = 0.83) when starting from their precursorsGAP (C3) and PYR (C3) or AcCoA (C2). Regarding the
demand of ATP and NADPH, they show only minor dif-
ferences as the DXP pathway needs one mol more
NADPH but one mol less ATP than the MVA pathway.
Hence, a priori, one could assume that no significant
differences in achievable IPP yields occur between
E. coli and S. cerevisiae.
Metabolic potential of wild type E. coli and S. cerevisiae to
supply IPP
Both terpenoid pathways are now analyzed with respect
to the metabolic background of their respective host. A
first comparison of the maximal IPP yields purely based
on carbon stoichiometry, ignoring energy and redox
equivalent requirements (i.e. when ATP and NAD(P)H
are initially considered to be external metabolites in the
model), shows a significant difference. With energy and
redox equivalents in excess, the maximum IPP yield on
glucose via the DXP pathway in E. coli is 5/6 = 0.83 C-
mol/C-mol compared to 5/9 = 0.56 C-mol/C-mol in
S. cerevisiae if the MVA pathway is used (Figure 1). This
is due to different amounts of carbon loss via CO2 in the
formation of the terpenoid pathway precursors. The for-
mation of one mol acetyl-CoA, the precursor of the
MVA pathway, includes the generation (and thus carbon
loss) of one mol CO2. In contrast, the formation of one
mol pyruvate and one mol glyceraldehyde-3-phosphate,
the precursors of the DXP pathway, does not involve a
carbon loss via CO2.
Besides the different carbon use efficiencies, the en-
ergy and redox equivalent requirements for IPP syn-
thesis differ in E. coli and S. cerevisiae as well (Figure 1).
For the formation of one mol IPP from glucose
(GLC) in E. coli, the overall stoichiometry is given by
equation 3.
GLCþ 2 ATPþ 3 NADPHþNADþ
¼ IPPþ CO2 þ 2 ADPþ 3 NADPþ þNADH ð3Þ
In S. cerevisiae, the overall stoichiometry for synthesiz-
ing one mol IPP with glucose as substrate via the MVA
pathway (considering only the constitutive NADP+-
dependent aldehyde dehydrogenase, ALD6) is given by
equation 4.
1:5 GLCþ 3 ATPþNADPþ þ 3 NADþ
¼ IPPþ 4 CO2 þ 3 AMPþNADPHþ 3 NADH ð4Þ
Now, in the context of the metabolic background,
significant differences are observed. When the path-
ways are considered isolated from the network, they
can both serve as redox sinks as they require reduced
redox equivalents (see equations 1 and 2). However,
due to the synthesis of the specific pathway precursors,
different energy and redox equivalent requirements
Table 1 Overview of in silico computations: number of elementary modes (EMs) and maximal IPP and biomass carbon
yields on different carbon sources [C-mol/C-mol] for computations for E. coli and S. cerevisiae
Organism Carbon
source






E. coli Glucose Wild type 36,590 0.67 0.57 0.85
E. coli Glucose Wild type, anaerobic 8,343 0.48 0.41 0.35
E. coli Glucose ATP source 48,603 0.71 0.57 0.99
E. coli Glucose NADH source 45,570 0.83 0.57 0.99
E. coli Glucose NADPH source 44,842 0.83 0.57 0.99
E. coli Glucose GAP-DH (NADP+) 74,651 0.71 0.62 0.99
E. coli Glucose MVA only 35,968 0.56 0.54 0.85
E. coli Glucose MVA + DXP 44,850 0.67 0.59 0.85
E. coli Glycerol Wild type 26,160 0.78 0.77 0.99
E. coli Glycerol ATP source 29,088 0.83 0.77 0.99
E. coli Glycerol NADH source 29,126 0.83 0.77 0.99
E. coli Glycerol NADPH source 28,252 0.83 0.77 0.99
E. coli Glycerol GAP-DH (NADP+) 62,665 0.83 0.77 0.99
E. coli Glycerol MVA only 22,225 0.56 0.45 0.99
E. coli Glycerol MVA + DXP 28,326 0.78 0.77 0.99
S. cerevisiae Glucose Wild type 9,844 0.53 0.39 0.80
S. cerevisiae Glucose Wild type, anaerobic 495 0.10 0.09 0.21
S. cerevisiae Glucose ATP source 15,326 0.56 0.39 0.89
S. cerevisiae Glucose NADH source 12,080 0.56 0.39 0.89
S. cerevisiae Glucose PDH 17,943 0.56 0.51 0.81
S. cerevisiae Glucose Mitochondrial MVA only 10,232 0.56 0.51 0.80
S. cerevisiae Glucose Mitochondrial + cytosolic MVA 128,427 0.56 0.53 0.82
S. cerevisiae Glucose ACL 17,155 0.55 0.39 0.80
S. cerevisiae Glucose DXP only 8,865 0.64 0.57 0.80
S. cerevisiae Glucose DXP +MVA 11,738 0.64 0.57 0.80
S. cerevisiae Glucose DXP + ATP source 13,731 0.66 0.57 0.89
S. cerevisiae Glucose DXP + NADH source 10,714 0.66 0.57 0.89
S. cerevisiae Glucose DXP + NADPH source 16,754 0.80 0.57 0.89
S. cerevisiae Glucose DXP + TH 25,254 0.67 0.57 0.81
S. cerevisiae Glucose DXP + GAP-DH (NADP+) 28,383 0.67 0.57 0.81
S. cerevisiae Galactose Wild type 9,844 0.53 0.39 0.80
S. cerevisiae Fructose Wild type 9,844 0.53 0.39 0.80
S. cerevisiae Xylose XI 6,330 0.53 0.39 0.80
S. cerevisiae Xylose XR-XDH 16,911 0.53 0.51 0.80
S. cerevisiae Xylose XI + DXP only 7,364 0.64 0.42 0.80
S. cerevisiae Xylose XI + DXP +MVA 9,088 0.64 0.44 0.80
S. cerevisiae Xylose XR-XDH + DXP only 16,513 0.64 0.42 0.80
S. cerevisiae Xylose XR-XDH + DXP +MVA 20,337 0.64 0.51 0.80
S. cerevisiae Glycerol Wild type 2,648,133 0.56 0.47 0.87
S. cerevisiae Glycerol Wild type w/o glyoxylate cycle 5,377 0.56 0.35 0.87
S. cerevisiae Glycerol DXP only 2,401,411 0.67 0.60 0.87
S. cerevisiae Glycerol DXP +MVA 4,038,007 0.67 0.60 0.87
S. cerevisiae Glycerol DXP + NADPH source 3,735,984 0.83 0.80 0.94
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Table 1 Overview of in silico computations: number of elementary modes (EMs) and maximal IPP and biomass carbon
yields on different carbon sources [C-mol/C-mol] for computations for E. coli and S. cerevisiae (Continued)
S. cerevisiae Glycerol DXP + GAP-DH (NADP+) 6,153,971 0.76 0.63 0.90
S. cerevisiae Ethanol Wild type 2,874,235 0.68 0.59 0.78
S. cerevisiae Ethanol ATP source 3,559,725 0.83 0.59 0.81
S. cerevisiae Ethanol NADH source 3,635,994 0.83 0.62 0.81
S. cerevisiae Ethanol DXP only 2,846,217 0.63 0.57 0.78
S. cerevisiae Ethanol DXP +MVA 3,133,493 0.68 0.59 0.78
GAP-DH (NADP+) = NADP+-dependent glyceraldehyde-3-phosphate dehydrogenase; PDH = cytosolic pyruvate dehydrogenase complex; ACL = ATP-citrate-lyase;
TH = soluble and energy-independent transhydrogenase; XI = xylose isomerase pathway; XR-XDH = xylose reductase and xylitol dehydrogenase pathway.
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E. coli, the synthesis of IPP is still accompanied by oxi-
dation of NADPH (equation 3) whereby in S. cerevisiae
reduced redox equivalents are generated (equation 4).
In both organisms, additional ATP has to be generated
from the substrate for IPP synthesis, which leads to a
further reduction of the maximum IPP yield.
Taking the cofactors explicitly into account requires a
network-wide view of all pathways. Therefore, elementary
mode analysis was performed on the metabolic networks
of E. coli (DXP pathway) and S. cerevisiae (MVA pathway)
wild types with glucose as the single carbon source. InFigure 1 Comparison of the DXP and MVA pathway. A section of the c
including glycolysis and DXP pathway, and B: of S. cerevisiae including glyc
stoichiometry and ignoring energy and redox equivalent requirements (5/6
via CO2 in the formation of the precursors pyruvate (PYR) and glyceraldehy
requirements and redox equivalents that have to be balanced by the orga
dehydrogenase (ALD6) is constitutive while cytosolic NAD+-dependent alde
repressed [51] and were not considered.total, 36,590 elementary modes were obtained for the
E. coli network and 9,844 for the S. cerevisiae network
(Figure 2). Of these, 2,597 modes (26.4%) of S. cerevisiae
and even 7,675 modes (21.0%) of E. coli include IPP for-
mation. Computed elementary modes exhibit different
yields for IPP and biomass in both organisms (Figure 2).
The maximum IPP yield for E. coli is 0.67 C-mol/C-mol
and 0.53 C-mol/C-mol for S. cerevisiae. If only elementary
modes that couple IPP synthesis with biomass formation
are considered, the maximum IPP yield drops to 0.57
C-mol/C-mol in E. coli and 0.39 C-mol/C-mol in
S. cerevisiae, respectively.entral carbon metabolism from glucose (GLC) to IPP: A: of E. coli
olysis and the MVA pathway. The maximal IPP yields based on carbon
= 0.83 and 5/9 = 0.56 C-mol/C-mol) differ due to different carbon loss
de-3-phosphate (GAP) or acetyl-CoA (AcCoA). The sum shows energy
nism’s metabolism. *: Note that cytosolic NADP+-dependent aldehyde
hyde dehydrogenases (ALD2, ALD3) are stress-induced, glucose-
Figure 2 Comparison of the solution space spanned by elementary modes. A: Wild type network of E. coli (36,590 EMs). B: Wild type
network of S. cerevisiae (9,844 EMs). The biomass yield on glucose is plotted against the IPP yield on glucose [C-mol/C-mol] for all computed
elementary modes. Elementary modes on the axes represent modes producing either only biomass (x-axis) or only IPP (y-axis). Theoretical
maximal IPP yields at zero growth as well as with biomass formation are highlighted.
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vide IPP, the common terpenoid precursor.
Comparison of flux distributions with maximum
IPP production
The differences in carbon stoichiometry of both IPP
forming pathways, in energy and redox equivalent re-
quirements as well as in the two hosts’ central carbon
metabolisms lead to different theoretical maximal IPP
yields. A comparison of the theoretical flux distribu-
tions in both organisms provides a detailed picture of
the reactions involved and reveals key pathways con-
tributing to maximum IPP production as well as path-
ways that could be dispensable. Furthermore, they show
limitations and provide valuable starting points for
metabolic engineering. For E. coli and S. cerevisiae, two
and five elementary modes enable the optimum yield,
respectively. In this subsection, main characteristics of
these optimal flux distributions are discussed. The flux
maps of one particular optimal mode for each case are
shown in Figures 3 and 4, respectively.
Yield optimal flux distributions in E. coli In E. coli, 3
NADPH as well as 2 ATP are needed for the production
of one mol IPP from one mol glucose (see above). In the
optimal case, NADPH is provided by a transhydrogenase,
an enzyme which transfers reducing equivalents between
two nucleotide acceptors to balance the intracellular redox
potential (6 NADH+ 6 NADP+ + 2 ATP = 6 NADPH + 6
NAD+ + 2 ADP). However, this leads to an increased re-
quirement for ATP and NADH. Thus, the cell is forced
to branch off some carbon flux to the citric acid cycle to
generate NADH and ATP as shown in the optimal flux
distributions (Figure 3). NADPH is not provided by the
oxidative part of the pentose phosphate pathway in thiscase due to increased carbon loss via CO2 which leads
to decreased IPP yields. The main flux passes through
glycolysis and DXP pathway, while a portion passes
pyruvate dehydrogenase complex and citric acid cycle
to generate ATP, NADH and NADPH along with re-
spiratory chain and transhydrogenase. The high branch-
off leads to a carbon loss and thus to a reduction in the
maximum IPP yield from 0.83 (if carbon stoichiometry
is considered only) to about 0.67 C-mol/C-mol in the
optimal flux distributions (Figure 3, see also Table 1).
Some fluxes are flexible within optimal elementary modes
namely those of malate dehydrogenase, malate quinone
oxidoreductase as well as NADH dehydrogenase II indi-
cating a certain flexibility in redox balancing which does
not influence the IPP yield. Optimal IPP production does
not involve any by-product formation except CO2 and is
purely respirative. However, fermentative modes show
high product yields as well, up to 0.48 C-mol/C-mol.
The limitation in redox equivalents and energy for
high yield IPP production can be validated in silico via
the introduction of additional artificial ATP, NADH or
NADPH sources in the metabolic network model. The
introduction of an artificial ATP source increases the
maximum yield slightly to 0.71, while artificial NADH or
NADPH sources lead to the theoretical maximum value
of about 0.83 C-mol/C-mol (as discussed in the previous
section).
Yield optimal flux distributions in S. cerevisiae In
S. cerevisiae, 3 NADH and one NADPH are produced via
glycolysis while 6 ATP are needed for the production of
one mol IPP from 1.5 moles glucose as described above.
Generated NADH can be reoxidized via the respiratory
chain to produce ATP. However, not enough ATP can be
produced due to the stoichiometry of the respiratory
Figure 3 Optimal flux distribution of E. coli. Wild type (DXP pathway) on glucose as single carbon source without biomass formation (one of
two modes with maximum theoretical IPP carbon yield). Numbers indicate relative molar fluxes (mmol/(gCDW h), CDW = cell dry weight)
normalized to glucose uptake. Grey reactions are not active (flux = 0). Variable fluxes within two optimal modes are marked with an asterisk (*).
Bold green arrows indicate biomass precursors.
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high yield IPP production and would be forced to branch
off some carbon flux to the citric acid cycle to generate
ATP via NADH. This branch-off is shown in the com-
puted optimal flux distributions (Figure 4). The main flux
passes glycolysis, pyruvate dehydrogenase bypass and
MVA pathway, while a small part is branched off topyruvate dehydrogenase complex and citric acid cycle in
the mitochondria to generate NADH which is then
reoxidized via the respiratory chain in order to produce
ATP. This branch-off leads to a further carbon loss and
thus to a reduction of the IPP yield to about 0.53 C-mol/
C-mol in the optimal flux distributions. As shown above,
the energy deficiency preventing high yield IPP production
Figure 4 Optimal flux distribution of S. cerevisiae. Wild type (MVA pathway) on glucose as single carbon source without biomass formation
(one out of five modes with maximum theoretical IPP carbon yield). Numbers indicate relative molar fluxes (mmol/(gCDW h), CDW = cell dry
weight) normalized to glucose uptake. Grey reactions are not active (flux = 0). Variable fluxes within the 5 optimal modes are marked with an
asterisk (*). Bold green arrows indicate biomass precursors.
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of an additional artificial ATP or NADH source in silico
which leads to the theoretical maximum value of about
0.56 C-mol/C-mol. Some fluxes are flexible within optimal
elementary modes namely those of mitochondrial and
cytosolic alcohol dehydrogenases and NAD+-dependent
aldehyde dehydrogenases as well as mitochondrialethanol, acetaldehyde and acetate transport and a redox
shuttle indicating a certain flexibility in NADH redox bal-
ancing which does not influence the IPP yield. The opti-
mal flux distributions are purely respirative modes.
Respiro-fermentative modes (modes that include respir-
ation as well as the formation of fermentation products)
show high product yields as well. However, pure
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etical maximum product yield of about 0.1 C-mol/C-mol.
High ATP requirements of the MVA pathway cannot be
delivered by fermentative metabolism. Additionally, the
formation of CO2, the only side-product, is much higher
than in optimal flux distributions in E. coli reflecting the
high carbon loss in the formation of acetyl-CoA.
Even though theoretical maximal yields differ in E. coli
and S. cerevisiae, the main flux in computed optimal flux
distributions at maximum IPP yield is similar. Key path-
ways are glycolysis and terpenoid pathway and a portion
of the flux is directed to citric acid cycle and respiratory
chain. Transhydrogenase is active in E. coli while pyru-
vate dehydrogenase bypass is active in yeast to supply
NADPH. Dispensable reactions include by-product for-
mation except CO2, gluconeogenetic and anaplerotic re-
actions as well as pentose phosphate pathway if no
biomass is produced. Limitations in redox equivalents
and energy for high yield IPP production could be vali-
dated in silico.
Exchange of terpenoid pathways
The MVA pathway from S. cerevisiae has been function-
ally introduced in E. coli and this strain produced sub-
stantially more terpenoid than strains with the native or
even engineered DXP pathway [17]. Due to this observa-
tion the MVA pathway was introduced in silico into E.
coli to analyze its effects on IPP production. The intro-
duction of the MVA and the removal of the DXP path-
way (35,968 EMs) lead to a theoretical maximum value
of about 0.56 C-mol/C-mol (which is slightly higher than
the value of 0.53 obtained for S. cerevisiae). No energy
or redox equivalent limitations exist for high yield IPP
production. E. coli possesses a cytosolic pyruvate dehydro-
genase complex instead of a pyruvate dehydrogenase
bypass (NADPH source). However, transhydrogenase,
Entner-Doudoroff pathway as well as malic enzyme can
act as NADPH source. Nevertheless, the sole use of the
MVA pathway in E. coli is stoichiometrically not efficient
as the maximum yield is lower than with the native DXP
pathway. The coexistence of both pathways in E. coli
(44,850 EMs, 1,207 of which that use both pathways sim-
ultaneously) leads to a theoretical maximum IPP yield of
0.67 C-mol/C-mol, which is identical to the value if only
the DXP pathway is active. However, the theoretical
maximum value in an elementary mode, which includes
biomass formation, is slightly enhanced to 0.59 C-mol/
C-mol. Thus, the coexistence of both pathways is not
only beneficial due to the decoupling of the MVA path-
way from its native control in yeast but also in terms of
stoichiometry.
In silico, the introduction of the DXP and the removal
of the MVA pathway in S. cerevisiae (8,865 EMs) lead to
an increase in the theoretical maximum IPP yield toabout 0.64 C-mol/C-mol, and 0.57 C-mol/C-mol includ-
ing biomass formation. The coexistence of both path-
ways in yeast (11,738 EMs, 276 of which that use both
pathways simultaneously) does not lead to a further en-
hanced IPP yield. Solely the number of elementary
modes and thus the flexibility is enhanced. The IPP car-
bon yield is slightly lower than that one of E. coli as
yeast does not possess a transhydrogenase to supply
NADPH. Hence, pentose phosphate pathway has to de-
liver NADPH which involves a carbon loss. Pyruvate
dehydrogenase bypass can deliver NADPH in the for-
mation of acetyl-CoA; however, acetyl-CoA is not needed
for the DXP pathway. The limitation in energy and
redox equivalents can be validated in silico by the intro-
duction of artificial ATP, NADH and especially NADPH
sources in the model, which lead to an enhanced theor-
etical maximum IPP yield of 0.66-0.8 C-mol/C-mol (see
Table 1).
In conclusion, the heterologous introduction of the
MVA pathway, in addition to the DXP pathway, into
E. coli as well as the introduction of the DXP pathway
into S. cerevisiae are theoretically beneficial for high yield
IPP production. Although, the DXP pathway has not been
functionally expressed in S. cerevisiae yet [13,52], it is a
promising target for further research.
Comparison of carbon sources
Studies showed that different carbon sources might have
a different potential to supply high product yields
[8,17,25]. At present, glucose is the most widely used
feedstock in bioprocesses [53]. However, other carbon
sources are of industrial interest and could serve as sub-
strate for terpenoid production. Molasses consists
mainly of sucrose, a disaccharide composed of glucose
and fructose, and is a commonly used carbon source
[54]. Hemicellulosic hydrolysates of agricultural by-
products like sugarcane bagasse or wood consist mainly
of xylose and glucose as well as other sugars like galact-
ose [55] and could be a cheap alternative carbon source
for bioprocesses [56]. Pure glycerol is used in different
industries too and crude glycerol could be a cheap alter-
native as it is a by-product from biodiesel production
with decreasing price [53,57]. Thus, EMA was further
performed for glycerol for E. coli. Moreover, the carbon
sources galactose, fructose and xylose were analyzed for
S. cerevisiae as well as glycerol and ethanol because high
terpenoid yields have been described with this substrate
[8]. The metabolic networks of the non-fermentable car-
bon sources ethanol and glycerol involve the glyoxylate
cycle and an increased number of mitochondrial shuttles
in yeast.
Alternative substrate for E. coli The maximum IPP
yield in E. coli on the non-fermentable carbon source
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NAD(P)H considered as external metabolites) is identi-
cal to that on glucose (0.83 C-mol/C-mol). The overall
stoichiometry for the formation of one mol IPP from
glycerol is given by equation 5.
2 GLYC þ 2 ATPþNADPHþNADþ
¼ IPPþ CO2 þ 2 ADPþNADPþ þNADH ð5Þ
The carbon loss for the formation of IPP from glycerol
is identical to glucose. However, less NADPH is required
as it is supplied by glycerol-3-phosphate dehydrogenase. If
the balances of ATP, NADH and NADPH are taken into
account, the yields for E. coli and the native DXP pathway
on glycerol (26,160 EMs) were enhanced in comparison to
glucose in silico (0.78 C-mol/C-mol at zero growth and
0.77 C-mol/C-mol in an elementary mode that includes
biomass formation). Yields were slightly lower for the
heterologous MVA pathway (0.56 C-mol/C-mol at zero
growth and 0.45 C-mol/C-mol including biomass forma-
tion). Thus, glycerol and the native DXP pathway have the
highest potential for E. coli to support high IPP produc-
tion. The main flux in optimal flux distributions passes
lower part of glycolysis and DXP pathway, while only a
small portion is diverted to citric acid cycle, respiratory
chain and transhydrogenase to generate NADPH, NADH
and ATP. The limitation in energy and redox equivalents
for high yield IPP production can be validated in silico by
the introduction of artificial ATP, NADH or NADPH
sources in the model, which lead to the maximum IPP
yield of 0.83 C-mol/C-mol (see Table 1).
Alternative substrates for S. cerevisiae The carbon as
well as the overall stoichiometry for the formation of
one mol IPP from galactose or fructose is identical to
glucose (see equation 4). Accordingly, the numbers of
elementary modes as well as the IPP and biomass yields
with galactose and fructose are identical to those with
glucose. A heterologous pathway has to be introduced
into S. cerevisiae for xylose as wild type strains are not
able to grow on the pentose xylose. Two different path-
ways have been used for ethanol production based on
xylose with yeast: the xylose isomerase (XI) pathway as
well as the xylose reductase and xylitol dehydrogenase
(XR-XDH) pathway [58]. The carbon stoichiometry for
the formation of one mol IPP from xylose is identical to
glucose (maximum 0.56 C-mol/C-mol). Likewise, the
overall stoichiometry is identical to the one on glucose
for the XI pathway except that 1.8 mol xylose (XYL) is
needed per mol IPP (equation 6).
1:8 XYLþ 6 ATPþNADPþ þ 3 NADþ
¼ IPPþ 4 CO2 þ 6 ADPþNADPHþ 3 NADH ð6ÞThe overall stoichiometry is identical for the XR-XDH
pathway if xylose reductase uses NADH (as xylitol de-
hydrogenase delivers NADH) and slightly changes if the
enzyme uses NADPH. The theoretical maximal IPP and
biomass yields are identical to the values on glucose for
both the XI (6,330 EMs) and the XR-XDH pathway
(16,911 EMs). However, the IPP yield including biomass
formation is enhanced to 0.51 C-mol/C-mol with the
XR-XDH pathway. The number of elementary modes
and thus the flexibility of the metabolic network is
greatly enhanced if the XR-XDH pathway is chosen. The
optimal flux distributions were basically identical to
those on glucose except that xylose enters glycolysis via
the non-oxidative part of pentose phosphate pathway.
The maximum IPP yield on the non-fermentable car-
bon source glycerol (GLYC) purely based on carbon stoi-
chiometry (ignoring energy and redox equivalents) is
with 0.56 C-mol/C-mol identical to glucose. However,
the overall stoichiometry is slightly modified (equation 7).
3 GLYCþ 3 ATPþNADPþ þ 6 NADþ
¼ IPPþ 4 CO2 þ 3 ADPþNADPHþ 6 NADH ð7Þ
Less energy is required and more NADH is delivered
for the production of one mol IPP from glycerol. Gly-
cerol is channeled into glycolysis via glyceraldehyde-3-
phosphate and the main flux passes lower part of
glycolysis, pyruvate dehydrogenase bypass and the MVA
pathway. The carbon flux is not diverted to citric acid
cycle as enough energy is produced via NADH and re-
spiratory chain. Thus, the maximum IPP yield of 0.56
C-mol/C-mol is achieved, which is identical to the max-
imum IPP yield based on carbon stoichiometry only. No
limitations in energy or redox equivalent requirements
thus exist for high yield IPP production. The optimal flux
distributions further reveal that pentose phosphate path-
way, side product formation, the first part of citric acid
cycle as well as glyoxylate cycle are not active. Some fluxes
are flexible namely those of alcohol dehydrogenases,
NAD+-dependent aldehyde dehydrogenases, second part
of citric acid cycle as well as mitochondrial transport
systems indicating a certain flexibility in NADH redox
balancing which does not influence the IPP yield. The
very high number of elementary modes (2,648,133 EMs)
implies an increased redundancy and thus network flexi-
bility and is due to the activity of the glyoxylate cycle.
The glyoxylate cycle showed only a weak activity in yeast
cells grown on glycerol in our experiments (data not
shown). If the cycle is excluded from the computations,
the number of elementary modes decreases (5,377 EMs)
but the theoretical maximum IPP yield remains 0.56
C-mol/C-mol. Nevertheless, the IPP yield including
biomass formation is much higher if the cycle is included
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that an active glyoxylate cycle could be of benefit.
The maximum IPP yield on the non-fermentable car-
bon source ethanol purely based on carbon stoichiom-
etry is with 0.83 C-mol/C-mol as high as the IPP yield in
E. coli. The overall stoichiometry for the formation of
one mol IPP from ethanol (EtOH) is given by equation 8.
3 EtOHþ 9 ATPþNADPþ þ 3 NADþ
¼ IPPþ CO2 þ 9 ADPþNADPHþ 3 NADH ð8Þ
In contrast to glucose or glycerol as the carbon
source, the formation of IPP from ethanol requires
more energy but does not involve an additional carbon
loss via CO2 (except the carbon loss in the terpenoid
pathway itself ). In fact, similarly to glycerol and E. coli,
ethanol (2,874,235 EMs) reveals an increased theoretical
maximum product yield of 0.68 C-mol/C-mol at zero
growth as well as 0.59 C-mol/C-mol including biomass
formation for the MVA pathway. The high number of
elementary modes is again due to the activity of the
glyoxylate cycle. The optimal flux distributions of yeast
(without biomass formation) with only the MVA path-
way reveal that the glycolysis, gluconeogenesis, pentose
phosphate pathway and side product formation are not
active. The flux passes pyruvate dehydrogenase bypass,
glyoxylate cycle as well as citric acid cycle and respiratory
chain to generate ATP. The energy deficiency preventing
high IPP yields can be validated in silico by introducing
artificial ATP or NADH sources which lead to the max-
imum yield of 0.83 C-mol/C-mol. As expected from these
computations, the sesquiterpenoid yield of the same yeast
strain was increased significantly in vivo by changing the
carbon source from glucose (0.0111 C-mol/C-mol) to
ethanol (0.1867 C-mol/C-mol) [8].Table 2 Comparison of theoretical maximal IPP yields with pu
Organism Pathway Carbon source
E. coli DXP glycerol+
E. coli DXP glycerol+
E. coli DXP +MVA glycerol+
S. cerevisiae MVA glucose+
S. cerevisiae MVA glucose+
S. cerevisiae MVA galactose
S. cerevisiae MVA glucose
S. cerevisiae MVA glucose
S. cerevisiae MVA glucose&ethanol
S. cerevisiae MVA ethanol
Experimental yields of sesquiterpenoids are partly estimated and converted into IPP
terpenoid); + indicates complex media.The introduction of the DXP pathway in silico and the
growth on galactose, fructose or xylose lead to similar yields
to those on glucose, except that the theoretical maximal IPP
yields including biomass formation are slightly increased on
xylose. With ethanol as substrate, the heterologous DXP
pathway shows a lower potential compared to the native
MVA pathway, with yields of 0.63 C-mol/C-mol at zero
growth and 0.57 C-mol/C-mol including biomass formation.
Lower yields are due to energy-consuming gluconeogenetic
reactions which are essential to provide the precursors of
the DXP pathway from ethanol. Nevertheless, the introduc-
tion of the DXP pathway could be beneficial for growth on
glycerol. The theoretical maximum IPP yield is enhanced to
0.67 C-mol/C-mol at zero growth and 0.6 C-mol/C-mol
including biomass formation. The cells would have a limita-
tion in NADPH for high yield IPP production, which can be
validated via the introduction of an artificial NADPH source
leading to the maximum value of 0.83 C-mol/C-mol.
To summarize this subsection, sugars like glucose,
galactose, fructose and even xylose lead to identical or
similar theoretical maximal IPP yields in S. cerevisiae
while the non-fermentable carbon sources ethanol and
glycerol show the highest potential with respect to yield
and network flexibility. Similarly, glycerol shows the
highest potential in E. coli to supply IPP in high yields.
Comparison of theoretical yields with experimental yields
reported in literature
A comparison of computed theoretical maximal IPP
yields with terpenoid yields published in literature is
shown in Table 2. The experimental carbon yields are
still very low, even though strains used in these studies
had been genetically modified within the respective ter-
penoid pathway. This highlights the tremendous poten-
tial of yield improvement. The terpenoid yield for yeastblished terpenoid yields (given as C-mol/C-mol)
Maximum IPP yield
(this study)












yields (only to that part of IPP that has been converted to the respective
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the capacity of the terpene synthase or the terpenoid
pathway (MVA) are not the only limiting factors but that
the flux into these pathways is a limiting factor on other
carbon sources like glucose. This shows that, besides the
already very well-studied modifications within the ter-
penoid pathway, genetic modifications within the central
carbon metabolism are indispensable to efficiently redir-
ect the carbon flux to the terpenoid pathway (‘push and
pull’ strategy).
Target identification for metabolic engineering
Identification of overexpression targets
The identified limitations in the generation of sufficient
energy and redox equivalents for high yield IPP produc-
tion with both organisms can be used as starting point
for metabolic engineering. Evidently, a reasonable ap-
proach would be to implement heterologous enzymes
that are more efficient with respect to NAD(P)H or ATP
consumption.
For E. coli, an increase in the maximum yield could
be accomplished by the introduction of alternative
pathways with less energy requirements or additional
NAD(P)H sources. For instance, an additional heterol-
ogous NADP+-dependent glyceraldehyde-3-phosphate
dehydrogenase enhances the theoretical maximum IPP
yield to 0.71 C-mol/C-mol on glucose and to 0.83
C-mol/C-mol on glycerol.
For S. cerevisiae, an increase in the maximum IPP
yield could be accomplished by the introduction of
alternative pathways with less energy requirements.
S. cerevisiae possesses a mitochondrial pyruvate de-
hydrogenase complex and a cytosolic pyruvate dehydro-
genase bypass to produce acetyl-CoA. Solely acetyl-CoA
produced via the bypass, which requires ATP, can be
used for terpenoid production since acetyl-CoA cannot
be exported from the mitochondria. In contrast, E. coli
possesses a cytosolic pyruvate dehydrogenase complex,
which does not require energy in the form of ATP. In
silico, a heterologous introduction of cytosolic pyruvate
dehydrogenase complex from E. coli into S. cerevisiae
leads to the theoretical maximum IPP yield of 0.56 C-mol/
C-mol and to a mode enabling biomass formation coupled
to an increased IPP yield of 0.51 C-mol/C-mol on glucose.
A cytosolic pyruvate dehydrogenase complex has to our
knowledge not been introduced into yeast with the aim of
enhancing terpenoid production. Though, a patent appli-
cation indicates that the complex of E. coli (lpdA, aceA,
aceF) might increase the cytosolic acetyl-CoA pool for bu-
tanol production [63].
A different approach would be to transfer the native
MVA pathway from S. cerevisiae into the mitochondria.
Likewise, on glucose, the theoretical maximum IPP yield
at zero growth is enhanced to 0.56 C-mol/C-mol andthe IPP yield including biomass formation is enhanced
to 0.51 C-mol/C-mol, if only the MVA in the mitochon-
dria is active, or to 0.56 and 0.53 C-mol/C-mol if the
MVA is active in the cytosol and the mitochondria.
The mitochondrial IPP and DMAPP as well as the FPP
pool have been harnessed successfully for terpenoid
production [10]. However, the whole MVA pathway has
not been transferred to the mitochondria. The advan-
tage of this approach would be that the mitochondrial
acetyl-CoA pool, which is formed via the pyruvate de-
hydrogenase complex that does not require ATP, would
be used.
Alternatively, an ATP-citrate-lyase can be expressed het-
erologously in the cytosol. The enzyme forms cytosolic
acetyl-CoA from citrate that has been exported from the
mitochondria and thus circumvents pyruvate dehydrogen-
ase bypass. The reaction is accompanied by the conversion
of one mol ATP to ADP per acetyl-CoA, while the cyto-
solic pyruvate dehydrogenase bypass converts in the net
one mol ATP to AMP. Thus, ATP-citrate-lyase is more
energy-efficient and thus promising. The theoretical max-
imum IPP yield at zero growth is indeed enhanced to 0.55
C-mol/C-mol. Moreover, a patent application indicates
that this approach might be promising [64].
If the DXP pathway is introduced into yeast, a heterol-
ogous soluble transhydrogenase leads to a higher theor-
etical maximum IPP yield of 0.67 C-mol/C-mol on
glucose. However, the introduction of a heterologous
soluble transhydrogenase from Azotobacter vinelandii as
well as the introduction of a membrane-bound enzyme
from E. coli into S. cerevisiae led to a reduction of the
NADPH pool including an increase in glycerol forma-
tion [65-67], which is the opposite of the desired effect.
Though, the introduction of a heterologous NADP+-
dependent glyceraldehyde-3-phosphate dehydrogenase
leads in silico to the same improvement in IPP yield on
glucose and to a yield of 0.76 C-mol/C-mol on glycerol.
Identification of knockout strategies
The constrained minimal cut sets (cMCSs) approach al-
lows the identification of all possible knockout combina-
tions that eliminate undesired (low-yield) elementary
modes and keep desired modes, which (i) have a specified
minimum product yield and (ii) allow at least some bio-
mass formation [40]. Hence, a selection pressure imposed
by gene deletions forces the cell to produce a predefined
minimum IPP yield to be able to grow. However, optimal
biological functions are acquired through evolutionary
processes. For in vivo validation, it has been shown that
adaptive evolution is essential to improve production cap-
abilities from sub-optimal metabolic states to optimal ones
as predicted from in silico analysis [68,69].
In this study, cMCSs are used to identify combina-
tions of gene deletions for both E. coli and S. cerevisiae
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engineering.
cMCSs for E. coli Constrained minimal cut sets were
computed for the E. coli wild type metabolic network on
glucose (36,590 EMs) as well as glycerol as carbon
source (26,160 elementary modes). For glucose, the dele-
tion task was defined by collecting all elementary modes
exhibiting an IPP yield lower than 0.25 C-mol/C-mol in
the set of target modes T˜ (33,087 EMs). The set of de-
sired modes D˜ comprises all EMs having (i) a minimum
IPP yield of 0.25 C-mol/C-mol; and (ii) a simultaneous
biomass yield necessarily higher than zero (268 modes)
(see Figure 5). When at least one EM of the set of D˜
should be preserved (n = 1; see Methods), a total of 488
cMCSs accomplishing the specified engineering goal
were computed. Cut sets including diffusion processes
or parts of respiratory chain were excluded from further
considerations due to poor feasibility leaving 28 cMCSs
with two or four interventions (see Table 3). One group
of cut sets forces a coupling of IPP production with bio-
mass formation via redox equivalents. This is achieved by
preventing oxygen uptake and thus respiration as well as
side product formation and reactions within citric acid
cycle that can reoxidize NADH (see Table 3). Hence,
NADH has to be reoxidized via transhydrogenase which
leads to excess NADPH production. Excess NADPH is
then reoxidized via the DXP pathway. Applying these cut
sets, the remaining elementary modes are anaerobic,
exhibit a minimum IPP carbon yield of 0.38 and the max-
imum anaerobic IPP yield of 0.48. However, the maximum
possible biomass carbon yield is very low. A second groupFigure 5 Concept of cMCSs illustrated with an example of E. coli. A: S
network of E. coli (36,590 EMs; compare Figure 2). The biomass yield on glu
computed elementary modes. The deletion task is defined by collecting all
of target modes T˜ (33,087 EMs). The set of desired modes D˜ comprises all
simultaneous biomass yield strictly higher than zero (268 EMs). B: Example
phosphoglycerate mutase (strategy 2 in Table 3) leads to a reduction of ele
minimum IPP yield of 0.28 and a maximum of 0.62 C-mol/C-mol as well as
modes, biomass formation is coupled to a minimum yield of IPP productioof cut sets includes the knockout of the lower part of
glycolysis to force the cell to use the Entner-Doudoroff
pathway instead, which results in less ATP but more
NADPH. The cell cannot reoxidize excess NADPH by the
additional knockout of transhydrogenase. Excess NADPH
is then reoxidized via the DXP pathway. Remaining elem-
entary modes are aerobic, exhibit a slightly lower mini-
mum IPP carbon yield but have a much higher maximum
biomass carbon yield than the anaerobic modes.
Another cut set included glucose-6-phosphate-isomer-
ase, transhydrogenase, Entner-Doudoroff pathway as
well as one specific part of respiratory chain. The cMCS
is not shown in Table 3 due to poor feasibility of the last
target. However, it serves as an example because it has
been implemented. The coupling is again due to excess
NADPH production. The knockout of glucose-6-phos-
phate-isomerase (Δpgi) has been done in E. coli in vivo
and led to an increased flux through pentose phosphate
pathway and thus to excess NADPH formation. How-
ever, an additional knockout of transhydrogenase (Δpgi
ΔudhA) was lethal due to NADPH imbalance in this
wild type strain [70]. This example illustrates that the
principle of the method is effective but regulatory con-
straints may interfere with proposed knockout strategies.
One can assume that the overexpression of a terpenoid
synthase together with the DXP pathway as a sink and
eventually adaptive evolution could balance the excess
NADPH production via a ‘push and pull’ strategy and
lead to the predicted coupling.
For glycerol, the deletion task was set up by (i) defining
T˜ as the set of elementary modes exhibiting an IPP yield
of not more than 0.33 C-mol/C-mol (22,801 EMs);olution space formed by the elementary modes of the wild type
cose is plotted against the IPP yield on glucose [C-mol/C-mol] of all
modes exhibiting an IPP yield lower than 0.25 C-mol/C-mol in the set
EMs having (i) a minimum IPP yield of 0.25 C-mol/C-mol; and (ii) a
of one specific cMCS. The in silico knockout of transhydrogenase and
mentary modes. Remaining elementary modes (191) display a
a maximum biomass yield of 0.41 C-mol/C-mol on glucose. In those
n.
Table 3 cMCSs for E. coli: number of remaining elementary modes (EMs), minimum and maximum IPP yield as well as
maximum biomass yield on glucose or glycerol [C-mol/C-mol] for different knockout strategies






Wild type on glucose 36,590 - 0.67 0.85
Strategy 1: O2 uptake + {lactate ex OR lactate formation} + {ethanol ex OR ethanol formation OR
acetaldehyde formation} + {succinate ex OR succinate OR malate DH OR fumarate hydratase}
60-86 0.38 0.48 0.08
Strategy 2: transhydrogenase + {phosphoglycerate mutase OR enolase} 191 0.28 0.62 0.41
Strategy 3: transhydrogenase + {GAP DH OR phosphoglycerate kinase} 191 0.35 0.62 0.32
Wild type on glycerol 26,160 - 0.78 0.99
Strategy 1: transhydrogenase + pyruvate kinase + pyruvate DH complex + ribulose-phosphate
3-epimerase + acetate formation + glyoxylate shunt + {succinate DH OR fumarate hydratase}
22 0.38 0.68 0.40
DH = dehydrogenase; ex = excretion.
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0.33 C-mol/C-mol and a simultaneous biomass formation
strictly higher than zero (570 EMs); and (iii) demanding
that at least one EM of D˜ is preserved (n = 1). A total of
769 cMCSs were computed, while cut sets that cannot be
realized in practice (including diffusion processes, parts of
respiratory chain, ATP maintenance etc.) were excluded
from further considerations leaving only 8 cMCSs with
eight interventions each (see Table 3). Feasible minimal
cut sets include the knockout of transhydrogenase, pyru-
vate kinase, pyruvate dehydrogenase complex, ribulose-
phosphate 3-epimerase, acetate formation, glyoxylate
shunt and citric acid cycle (succinate dehydrogenase or fu-
marate hydratase). A minimum IPP carbon yield of 0.38
C-mol/C-mol can be guaranteed but only two of the
remaining elementary modes enable biomass formation.
The presented minimal cut set strategies can also be ap-
plied to E. coli strains carrying the additional MVA path-
way. The IPP and biomass yields of remaining elementary
modes are only slightly modified (results not shown).
The cMCSs approach points to new and promising
combinations of metabolic engineering targets. The pre-
dicted minimal IPP yields are much higher than the yields
that have been published in literature so far. Nevertheless,
kinetics and regulation, especially of the DXP pathway,Table 4 cMCSs for S. cerevisiae: number of remaining elemen
yield as well as maximum biomass carbon yield on glucose [C
cMCS knockout strategy
Wild type
Strategy 1: acetate ex + {ethanol ex OR alcohol DH} + {α-ketoglutarate DH O
Strategy 2: acetate ex + {ethanol ex OR alcohol DH} +malate DH +malic enz
Strategy 3: acetate ex + {ethanol ex OR alcohol DH} +malate DH + NAD+-de
DH + pyruvate DH complex
Wild type plus DXP pathway
Strategy 1: glucose-6-phosphate-isomerase
DH = dehydrogenase; ex = excretion.may impose additional challenges to be solved in order to
achieve high terpenoid yields with E. coli.
cMCSs for S. cerevisiae Constrained minimal cut sets
were computed based on the wild type metabolic net-
work with glucose as carbon source (9,844 EMs).
Modes exhibiting an IPP yield of not more than 0.25
C-mol/C-mol were collected in the set of target modes
T˜ (9,453 EMs). All EMs exhibiting (i) an IPP yield of
not less than 0.25 C-mol/C-mol; and (ii) a concurrent
biomass yield strictly higher than zero were defined as
desired modes D˜ (322 EMs). While preserving at least
one of the desired modes (n = 1), a total of 407 cMCSs
were computed. Cut sets including mitochondrial trans-
port systems, diffusion, ATP maintenance etc. were ex-
cluded from further considerations leaving 8 feasible
cMCSs with three to six interventions (Table 4). All
remaining cMCS require blocking of acetate secretion
and either of ethanol secretion or of all alcohol dehy-
drogenases (cytosolic and mitochondrial). The preven-
tion of acetate and ethanol production is crucial as
the engineering goal cannot be accomplished without
those two targets. An additional target is the partial
knockout of citric acid cycle after α-ketoglutarate,
namely α-ketoglutarate dehydrogenase or succinyl-CoAtary modes (EMs), minimum and maximum IPP carbon







9,844 - 0.53 0.80
R succinyl-CoA ligase} 142/48 0.33 0.53 0.29
yme 60/21 0.33 0.53 0.29
pendent isocitrate 51/19 0.27 0.53 0.37
11,738 - 0.64 0.80
631 0.37 0.63 0.35
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would be an alternative as well but were not consid-
ered due to possible succinate secretion). Alterna-
tively malate dehydrogenase and malic enzyme can be
deleted for a partial knockout of citric acid cycle. A
second alternative is malate dehydrogenase, NAD+-
dependent isocitrate dehydrogenase as well as pyru-
vate dehydrogenase complex.
Possible knockout combinations were simulated and
Table 4 shows the number of remaining elementary
modes and the minimal and maximal IPP and biomass
carbon yields when applying the respective cMCS. All
minimal cut sets lead to a reduced maximum biomass
yield and a reduced number of elementary modes. How-
ever, a certain flexibility is preserved. The IPP carbon
yield can reach the maximum value of the wild type, and
a minimum value of 0.27 or 0.33 is computed. Due to
the partial disruption of citric acid cycle the cell is not
able to convert glucose completely to CO2. Hence, the
cell is forced to secrete products like ethanol or acetate.
The repression of acetate and ethanol excretion forces
the cell to find another sink like IPP. Targets identified
for glucose can also be applicable to other sugars like
galactose or fructose.
The knockout of succinyl-CoA ligase (ΔLSC1) was
implemented in S. cerevisiae and an enhanced acetate se-
cretion was observed [71]. This indicates that the principle
of the method is effective even though acetate is produced
instead of channeling the flux to acetyl-CoA, the precur-
sor of the MVA pathway. Nevertheless, acetate secretion
can be lowered by the overexpression of acetyl-CoA syn-
thetase [48]. Moreover, an overexpression of the MVA
pathway together with a terpenoid synthase might channel
the flux to IPP via the ‘push and pull’ strategy.
cMCSs including a heterologous DXP pathway are
basically identical to those of the wild type. Thus,
presented strategies can also be applied to a strain carry-
ing an additional DXP pathway if the pathway was active
in vivo. However, the minimal IPP yields are unchanged
and thus the heterologous DXP pathway would be of no
benefit. Nevertheless, one additional interesting interven-
tion strategy was computed. The single knockout of
glucose-6-phosphate-isomerase leads to a coupling of
biomass formation to a minimal IPP yield of 0.37 C-mol/
C-mol. The knockout of glucose-6-phosphate-isomerase
forces the cell to direct the flux completely to pentose
phosphate pathway, which leads to excess NADPH pro-
duction. Wild type yeast cells are not able to compensate
excess NADPH as they do not possess a transhydrogenase.
Further, NADH dehydrogenases (Ndi1p, Nde1p, Nde2p)
do not oxidize NADPH and malic enzyme reaction seems
to be irreversible in vivo [72,73]. Yeast cells are not able to
grow on glucose after the knockout of PGI1 gene encoding
glucose-6-phosphate-isomerase [74] and no elementarymodes could be computed for the wild type network in-
cluding only the MVA pathway with the single knockout
of glucose-6-phosphate-isomerase. Nevertheless, an active
DXP pathway could serve as a NADPH sink as it requires
more NADPH and less ATP per mol IPP than the MVA
pathway.
Minimal cut sets were also computed for the meta-
bolic network with xylose as carbon source including ei-
ther the XI or the XR-XDH pathway together with the
MVA pathway. Identified knockout targets as well as
yields after the implementation of a minimal cut set for
the XI pathway are identical to those of glucose. Knock-
out targets for the XR-XDH pathway are different. Min-
imal cut sets only exist with an additional target,
ribulose-5-phosphate-3-epimerase in pentose phosphate
pathway. Cut sets including pyruvate dehydrogenase com-
plex do not exist. Moreover, possible IPP yields after the
implementation of a minimal cut set are slightly different
and can vary between 0.30 and 0.50 C-mol/C-mol.
To our knowledge, a disruption of citric acid cycle has
not been done with the aim to enhance terpenoid pro-
duction. Predicted minimal IPP yields are much higher
than yields that have been achieved in literature so far.
Thus, targets identified by the minimal cut sets ap-
proach are completely new and promising for an en-
hanced terpenoid yield on sugars with S. cerevisiae.
Moreover, the knockout of glucose-6-phosphate-isomerase
appears as a very promising strategy to enhance terpenoid
production if the DXP pathway can be functionally ex-
pressed in yeast.
Conclusions
The use and optimization of microorganisms for an eco-
logically and economically efficient production of plant
terpenoids is a contemporary issue in academic research
as well as industry. The most widely used model organ-
isms E. coli and S. cerevisiae as well as their respective
terpenoid pathway, heterologous enzymes and different
carbon sources have been analyzed in silico in this study
with respect to their potential as terpenoid factories.
The DXP pathway of E. coli has a tremendously higher
potential for high IPP yields (nearly 50% higher) than
the MVA pathway of yeast with respect to carbon stoi-
chiometry due to their different precursors. However,
kinetics, regulation and a balanced overexpression have
to be considered for in vivo production. Further research
should focus on the optimization of the DXP pathway to
tap its full potential. E. coli wild type shows a higher the-
oretical potential to supply IPP in high yields than
S. cerevisiae wild type. However, the theoretical maximal
yields can be enhanced in both organisms by introducing
heterologous enzymes or whole pathways or by simply
changing the carbon source. Moreover, new constrained
minimal cut set strategies can be applied to both hosts
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which is higher than any yield published in scientific lit-
erature so far.
Methods
Elementary modes and minimal cut sets
Consider a given metabolic reaction network with q × p
stoichiometric matrix N (with q reactions and p metabo-
lites) and a set Irrev of irreversible reactions. The set of
steady-state flux vectors r form the convex (flux) cone
reads:
F ¼ r ∈ Rq Nr ¼ 0; ri ≥ 0 ∀i ∈ Irrevgjf
An Elementary Mode is a non-decomposable vector e
∈ F , i.e. for every vector r ∈ F, r ≠ 0, one has supp(e)⊆
supp(r), where the support of a vector is defined as the
index set of all reactions carrying a non-zero flux (supp(r) =
{i | ri ≠ 0}). EMs correspond to minimal functional units
(pathways or cycles) of a metabolic network and are useful
to study various functional network properties [34,36].
In contrast, a minimal cut set (MCS) is a (support-)
minimal set C of reactions, the removal of which will
block (disrupt) a given set M of target flux vectors,
M⊆ F [75,76]:
r ∈ F ri ¼0; ∀i ∈ Cg ∩M ¼ ∅jf
One drawback of the original definition of MCSs is
that besides the targeted functionalities some desired
functionalities can be lost as well. Therefore, a generali-
zation to constrained MCSs was introduced [40] which
can be described as follows (in the following, EMs are
represented by their support, i.e. by the set of reactions
carrying a non-zero flux in the EM):
1) Define a set of target modes T˜ (where each target
mode t is represented by its support T = supp(t)).
2) Define a set of desired modes D˜ (where each desired
mode d is represented by its support D = supp(d)).
3) Specify a number n quantifying the minimal
number of EMs from D˜ that must be kept
in the network, i.e. a cMCS C fulfills:
∀T ∈ T˜ :C ∩ T≠∅∧ D ∈ D˜j D ∩ C¼∅gj≥n.
cMCSs provide a flexible and convenient approach for
formulating and solving intervention problems. The ap-
proach also allows one to compute interventions that
lead to robust coupling of product and biomass forma-
tion (coupling even for suboptimal growth). To compute
the cMCSs, we applied an adapted Berge algorithm
(allowing the computation of cMCSs as minimal hitting
sets of T˜ subject to D˜ and n), implemented in the soft-
ware package CellNetAnalyzer [77].Metabolic networks
A comprehensive analysis of the complete set of elemen-
tary modes is still infeasible with genome-scale metabolic
models. Therefore, stoichiometric models of the central
metabolism of E. coli and S. cerevisiae were built up
manually. The basic glucose network for E. coli consists of
65 reactions, of which 21 are reversible, and 50 metabo-
lites (12 external). For S. cerevisiae the basic glucose
network comprises 69 reactions, thereof 30 reversible, and
60 metabolites (8 external). The P/O-ratios (mol ATP pro-
duced per 0.5 mol O2 reduced) representing the efficiency
of ATP production are assumed to be 1.2 for S. cerevisiae
[78,79] and for E. coli 2 from NADH and 1 from quinol
[39,43,80]. The metabolic networks of S. cerevisiae and
E. coli have been constructed considering the current
knowledge from genome-scale models and literature data
[81-86]. The most important reactions are depicted in
Figures 3 and 4, respectively. Details of the models (in-
cluding the complete list of enzymes, genes and consid-
ered literature) are given in Additional file 1.
Additional file
Additional file 1: Metabolic networks. Metabolic networks of
S. cerevisiae and E. coli including the complete list of genes, heterologous
enzymes, alternative carbon sources and considered literature.
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